Xiaoqian Xu

State Key Lab Of Digestive Health, Beijing 10050
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A role of FURIN in promoting TGF-β signaling activation in MAFLD: Evidence from UK Biobank proteomic cohort.

A role of FURIN in promoting TGF-β signaling activation in MAFLD: Evidence from UK Biobank proteomic cohort.

Journal: International journal of biological macromolecules

Published: June 19, 2025

Impact of Alanine Transaminase Thresholds on Treatment Eligibility of Patients with Chronic Hepatitis B: A Cross-sectional Study of the China Registry of Hepatitis B.

Impact of Alanine Transaminase Thresholds on Treatment Eligibility of Patients with Chronic Hepatitis B: A Cross-sectional Study of the China Registry of Hepatitis B.

Journal: Journal of clinical and translational hepatology

Published: May 28, 2025

Dynamic Early Survival Prediction Model for Hepatocellular Carcinoma Patients Treated With Atezolizumab and Bevacizumab: A Longitudinal Deep Learning Analysis.

Dynamic Early Survival Prediction Model for Hepatocellular Carcinoma Patients Treated With Atezolizumab and Bevacizumab: A Longitudinal Deep Learning Analysis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 13, 2025

Unstable Recompensation: An Intermediate Subtype in Patients With HBV-Related Decompensated Cirrhosis.

Unstable Recompensation: An Intermediate Subtype in Patients With HBV-Related Decompensated Cirrhosis.

Journal: Alimentary pharmacology & therapeutics

Published: March 06, 2025

Early on-treatment LSM reliably predicts liver-related events in CHB patients with significant fibrosis and cirrhosis.

Early on-treatment LSM reliably predicts liver-related events in CHB patients with significant fibrosis and cirrhosis.

Journal: Hepatology (Baltimore, Md.)

Published: March 03, 2025

Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies.

Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies.

Journal: Gut and liver

Published: January 05, 2025

Identification of growth differentiation factor 15 as an early predictive biomarker for metabolic dysfunction-associated steatohepatitis: A nested case-control study of UK Biobank proteomic data.

Identification of growth differentiation factor 15 as an early predictive biomarker for metabolic dysfunction-associated steatohepatitis: A nested case-control study of UK Biobank proteomic data.

Journal: Diabetes, obesity & metabolism

Published: December 23, 2024

Impact of hepatitis B surface antigen quantification on achieving a functional cure in patients with chronic hepatitis B: A systematic review and meta-analysis.

Impact of hepatitis B surface antigen quantification on achieving a functional cure in patients with chronic hepatitis B: A systematic review and meta-analysis.

Journal: Annals of hepatology

Published: December 02, 2024

Non-canonical Wnt signaling pathway activated NFATC3 promotes GDF15 expression in MASH: prospective analyses of UK biobank proteomic data.

Non-canonical Wnt signaling pathway activated NFATC3 promotes GDF15 expression in MASH: prospective analyses of UK biobank proteomic data.

Journal: Hepatology international

Published: October 25, 2024

Correspondence to editorial on "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients".

Correspondence to editorial on "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients".

Journal: Clinical and molecular hepatology

Published: June 12, 2024

"Treat-all" Strategy for Patients with Chronic Hepatitis B Virus Infection in China: Are We There Yet?

"Treat-all" Strategy for Patients with Chronic Hepatitis B Virus Infection in China: Are We There Yet?

Journal: Journal of clinical and translational hepatology

Published: March 08, 2024

Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrieval.

Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrieval.

Journal: Journal of autoimmunity

Published: January 07, 2024

Showing 1-12 of 15

Last Updated: 09/26/2026